Our missions

Project owner support – Radiopharma


A major nuclear energy company is developing an innovative project to use an old waste product as an active ingredient in a new targeted cancer therapy. In parallel with the therapeutic development, the company has launched the construction of two manufacturing sites (one in the US, one in France) for the production of future tracers. These facilities will have to meet the requirements of aseptic production and the handling of radioactive products.


Based on its experience in the field of radiopharmaceuticals, ILS is assisting this industrialist with the French project by carrying out the criticality analysis of the new process and drafting the quality documentation (VMP, URS, System Impact Analysis, DQ, etc.). ILS also advises the project team on the organisation or technical choices impacting the future Pharmaceutical Establishment.

The mission




API / Fill & Finish




3-12 months



Investment cost

100 - 150 M€

Contact us

Whether you need help with a Life Science project or you’d like to know more about us, we’d love to hear from you.

    By completing and submitting this form, you agree that the information collected will be used in the context of the contact request and the commercial relationship that may result.

    * required fields

    You have the right to access, rectify and delete your personal data.
    See our privacy policy for details.